27 related articles for article (PubMed ID: 7538330)
21. Ten years of colony-stimulating factors: what have we learned? Introduction.
Sylvester RK
Am J Health Syst Pharm; 2002 Apr; 59(7 Suppl 2):S3-5; quiz S28-9. PubMed ID: 11944612
[No Abstract] [Full Text] [Related]
22. Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor.
Herman AC; Boone TC; Lu HS
Pharm Biotechnol; 1996; 9():303-28. PubMed ID: 8914196
[No Abstract] [Full Text] [Related]
23. [Filgrastim in the treatment of severe neutropenia in a patient with bilobar pneumonia].
Marcos Sánchez F; Juárez Ucelay F; Plaza Díaz R; Durán Pérez-Navarro A
An Med Interna; 1995 Feb; 12(2):100-1. PubMed ID: 7538330
[No Abstract] [Full Text] [Related]
24. Resolution of the neutropenia of Felty's syndrome by longterm administration of recombinant granulocyte colony stimulating factor.
Krishnaswamy G; Odem C; Chi DS; Kalbfleisch J; Baker N; Smith JK
J Rheumatol; 1996 Apr; 23(4):763-5. PubMed ID: 8730142
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
26. [Colony stimulating factors in blood formation].
Goebel M
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():51-6. PubMed ID: 7531048
[TBL] [Abstract][Full Text] [Related]
27. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
Kuritzkes DR
Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
